In just eight years, the world’s first completely robotic “hybrid” heart will be ready for transplant, according to the Daily Mail.

The Mediterranean diet has been eclipsed as the U.S. News & World Report’s best-ranked heart-healthy diet for the first time in a decade, nudged out of the top spot by the popular Ornish diet.

Repeat revascularization isn’t a rare occurrence after PCI or CABG, according to a study of patients with left main coronary artery disease—but it can raise a person’s risk of cardiovascular death by as much as four times.

This common gesture is meant to signal joy at the end of treatment, but it's producing the opposite effect for some oncology patients, according to a recent survey. 

The FDA has approved a Medtronic-run trial, PULSED AF, to evaluate the safety and efficacy of new tech that uses pulsed electric fields to treat AFib.

Burnout may increase a person’s risk of developing atrial fibrillation by as much as 20%, researchers reported this month in the European Journal of Preventive Cardiology.

A possible shortage of heparin, one of the most popular blood thinners on the market, is threatening the U.S., according to a viewpoint published in The Lancet on Jan. 23.

Injection drug users prescribed controlled release hydromorphone—an opioid—are three times more likely to develop endocarditis than users prescribed other opioids, according to work published Jan. 22 in The Lancet Infectious Diseases.